Skip to main content

Welcome to the UK Islet Autoantibody Registry

What is the registry? A registry of children, young people and adults who have markers of type 1 diabetes in their blood called islet autoantibodies and are at risk of, or have early-stage type 1 diabetes (T1D).

Join the Registry
Group of happy children aged 5 to 9 running with school bags on their backs
Water balloon fun activity
Toddler running on the beach

Our goals

Keep in touch with registry participants

To keep in touch with registry particpiants, to let them know about new research, available trials or treatments to delay or prevent type 1 diabetes.

Understand life with early-stage T1D

To understand what it is like knowing you have type 1 diabetes autoantibodies or early stage type 1 diabetes , in order to help develop better resources to support people.

Understand how long it takes people to develop stage 3 T1D

Collect data on how fast stage 3 T1D develops.

Work with patients and Diabetes UK to improve care

To work with public and patient groups and Diabetes UK to guide policy for their care.

About the Registry

Benefits of joining

Explore how joining can help you and others

Joining the registry helps you stay informed, access support, and contribute to better care for people at risk of type 1 diabetes.

  • Access advice and support: find out what it means if you have these markers and the options for follow-up
  • Learn about available new treatments and research to delay or prevent type 1 diabetes
  • Help us understand and tailor the support needed for people who will go on to develop type 1 diabetes and those who are at risk
  • Keep up to date with what we have learned and help shape future care policy and delivery
Join the Registry
Father holding his young child on a beach
Child Parent playing in the field

Partners and collaborators

University of Birmingham
University of Bristol
BSPED
Cardiff University
University of Dundee
Imperial College London
University of Exeter
King's College London
University of Oxford
UKT1D Research Consortium
Funded by
Diabetes UK